Ipca Laboratories Limited (NSE: IPCALAB) reported Revenue from Operations for Q3 FY23 of ₹1,546 Crore up from ₹1,430.47 Crore year on year, a growth of 8%. The Consolidated Net Profit of ₹107.84 Crore, down 45% from ₹196.96 Crore in the same quarter of the previous year. The Earnings per Share is ₹4.25 for this quarter.
Ipca Laboratories Limited Q3 FY23; Revenue Increased To ₹1,546 Crore
Tags: pharmaceuticals
Related Post
- Garden Reach Shipbuilders & Engineers Ltd Q2FY25; 10% rise in Profits
Garden Reach Shipbuilders & Engineers Ltd is a premier shipbuilding company in India under the…
-
GAIL (India) Ltd Q2FY25; 10% rise in Profits
Incorporated in 1984, GAIL, a Government of India undertaking, is an integrated natural gas company…
-
G R Infraprojects Ltd Q2FY25; 11% fall in Profits
Incorporated in the year 1995, G R Infraprojects Ltd is an integrated road Engineering, Procurement,…